ID	PFS_P	PFS_P_CNSR	AGE	SEX	TRT01P	PDL1FL
X00936b9285d6b8665ae9122993fb8e91	4.1724846	0	52	F	Avelumab+Axitinib	N
X105622fadc33f23755ac2df823110aca	16.59137577	1	78	M	Sunitinib	N
Xeb5718fc91df508b1eb43b77df50a828	8.706365503	0	52	F	Avelumab+Axitinib	NA
Xe44f39747a8e84b02b4cb24659312144	11.10472279	0	61	M	Sunitinib	Y
X293dd1284496215e9a0eca9f17a98e7e	14.02874743	1	55	M	Sunitinib	Y
X01ed7190ce00862696edbf047b542045	12.41889117	0	68	M	Sunitinib	Y
Xf4a6a5a1450a8448882e1c0aebc0eea5	13.83162218	1	70	M	Sunitinib	Y
Xf7ee4a331a8fd70edc240dff978c170d	13.8973306	1	53	M	Sunitinib	Y
Xd8e5f79b373bd33fe91174f9eb48620f	12.55030801	1	74	F	Sunitinib	N
Xcddbd4d01bc7513298a5135e97cfdb6b	1.511293634	0	52	M	Sunitinib	Y
Xa57451efa2822becb256706fe939d078	4.271047228	0	58	M	Avelumab+Axitinib	Y
X8ef44eaec6c293a0adbfc0e97ce7786d	5.059548255	0	55	M	Avelumab+Axitinib	NA
Xff8fbe2fe76c82d429d4fa1d315f3b93	11.20328542	1	75	F	Avelumab+Axitinib	Y
Xf9ad54895d67b651806deab25643ea6e	11.17043121	1	64	M	Sunitinib	Y
Xbe347643a72bb04ddd76a0edea8bbb7b	11.17043121	1	61	F	Avelumab+Axitinib	NA
X83864118183d6d44a78a1dcfd50420de	11.17043121	0	53	M	Avelumab+Axitinib	N
X270eb069e858ab11185487082313a8ba	3.318275154	1	80	M	Avelumab+Axitinib	N
X47156c2ebd5ab6bc3498b6dfb70e9de1	11.17043121	1	59	M	Sunitinib	Y
Xe84e18096d9fee062c34f394be7a8c8a	4.238193018	1	60	F	Sunitinib	NA
X33fe25b1ae7fa2d13b0cebf465cda997	2.891170431	0	50	F	Avelumab+Axitinib	Y
X97b6866aa994b9796e91aef65c9aa00a	1.412731006	0	49	M	Sunitinib	Y
X442022c1bed311912f07f2a084eb51e6	5.815195072	0	59	M	Avelumab+Axitinib	NA
X5698d14afa59bd77bef894d49d33c6d2	7.392197125	0	56	M	Sunitinib	Y
X3bb0665c45e2decbd5439bf13b7cd0ad	9.100616016	0	70	M	Sunitinib	Y
X2d6a79464a71daaa1047f0a261d5eb07	4.1724846	0	76	M	Sunitinib	Y
X97d1afa809fb0c655921c0ca2b2f9d64	9.691991786	1	54	F	Sunitinib	Y
X5f3b11e482ba5ccba88a68c876d2bd7f	7.260780287	1	52	M	Sunitinib	Y
X52bd90cd2fa84db3a6f636e10de7beda	8.31211499	0	80	F	Sunitinib	NA
X832e10f63e678f47e1ca9df1eed387d4	1.511293634	0	64	F	Avelumab+Axitinib	Y
X441f1fa08e92bc869755da2f1d547f92	5.585215606	0	77	M	Sunitinib	Y
Xdf77fa0206b384806716a8b4af61e60f	7.030800821	1	65	M	Sunitinib	N
X193d13fc662c7a4c86416d856d767d0e	7.12936345	1	64	F	Sunitinib	Y
X2d0a4d6a0245eddc55832f3567edc1b0	6.932238193	1	79	M	Avelumab+Axitinib	Y
Xfa384aff1a21a428ddc61730d791ac07	6.997946612	1	80	F	Sunitinib	Y
Xce653fac9fcd291555d86026cbbe73af	1.445585216	0	59	F	Avelumab+Axitinib	Y
Xaa1b3ba6002fdc8b8b13bc722b2fe074	6.965092402	1	60	M	Avelumab+Axitinib	Y
X4a34559af77fd876c74d98c1fd581aa2	7.09650924	1	56	M	Sunitinib	Y
X4c20c40030741ca8a07e483e26a19e67	1.412731006	1	32	M	Avelumab+Axitinib	Y
X99252e20f6fafaefaf3fadf51acc1ed2	1.577002053	0	71	M	Avelumab+Axitinib	Y
X07e01fdcb86fd0ab6446d7f20038d4a1	7.12936345	1	53	M	Sunitinib	Y
X8bbd8072d4cd190553dfaa7aaa7b19d6	2.858316222	0	69	M	Sunitinib	Y
X0bc0ebe2508cfcb3e0c4853061e2c638	6.965092402	1	79	F	Sunitinib	Y
X465cc3c79fc4e389e96b7d4775662bb0	1.281314168	0	53	F	Sunitinib	N
X6f5f07201e23cbc8659f078d29b36cac	5.716632444	1	50	M	Avelumab+Axitinib	Y
Xb0625cdb0ab1d45dd8bb0659c873c9a8	7.753593429	0	67	M	Sunitinib	NA
X6a295c4f7db25ea5ad800d1d9df4cdfb	0.032854209	1	29	F	Avelumab+Axitinib	Y
X5db3fb52bae7f0ca108b11eac258a5ea	16.13141684	0	66	M	Avelumab+Axitinib	N
X0d698cf8dde695f7a8cdfad41fad55f1	12.48459959	1	77	F	Avelumab+Axitinib	Y
X64875728bb1ba831bf8b886cbb20235b	4.205338809	0	57	F	Avelumab+Axitinib	Y
X419386e8a743aeb75391e63f78626066	8.607802875	1	55	M	Sunitinib	Y
Xb4d3796f66140d2b5995482c0403bf83	8.574948665	1	46	M	Avelumab+Axitinib	NA
Xd14fb91b737e78e07ee6622e56539dcd	4.238193018	0	70	M	Avelumab+Axitinib	Y
X111cb9fffc9fc55d838d097af1e3b727	5.650924025	1	66	M	Sunitinib	Y
Xbebf2ac740744d14a9c3196582773a65	23.62217659	1	59	M	Avelumab+Axitinib	Y
X55bb7aa07ad1c420285fa296f511e9fa	9.593429158	0	57	M	Sunitinib	Y
X115796797161bc75e7773610baae2a91	20.73100616	0	52	M	Sunitinib	NA
X7354734a2b7779fc172b8fa7062a7f3e	5.453798768	0	55	M	Sunitinib	Y
X31dc99ac3198e9b0437786a6f2edc50d	2.759753593	0	55	M	Avelumab+Axitinib	N
X52f703a2b6e5dab5d2ebebc819a4573e	7.030800821	0	52	M	Sunitinib	N
X03b6c4d96ebc5fa10c07e88cfc51667c	2.759753593	0	47	M	Sunitinib	Y
Xe3a92c49455bf11904afa9c1d9661350	15.21149897	0	60	M	Avelumab+Axitinib	Y
Xfab3b2d8b666d807064f44cf2671b1af	10.02053388	0	74	M	Avelumab+Axitinib	Y
X1cb9577d90b2a15e59959f7f911e6689	15.21149897	0	60	M	Avelumab+Axitinib	Y
X04051600478936d7e5bfff222f5391ca	11.07186858	0	65	F	Sunitinib	N
X7705345d3d9843faab494c3b8319a90a	4.1724846	0	65	F	Avelumab+Axitinib	N
X051ff3f6fc50a9899007b53b374ff36b	0.492813142	1	63	F	Sunitinib	Y
Xf00ad8a7026f9f410e9a4391d1787f46	2.792607803	0	39	M	Sunitinib	Y
X046d63897cffd07093069e1986db4014	18.0698152	1	73	M	Avelumab+Axitinib	Y
X52d32af145d65a9fd0a8f433dce1baa0	1.314168378	0	52	M	Sunitinib	Y
X872dded2f52f2be7d52eb034e273aba4	12.45174538	0	58	M	Sunitinib	N
X5baf5f197178a266431ca78d774ff73b	8.410677618	0	71	M	Avelumab+Axitinib	Y
X16772d239c75dacdd83f312235b63536	18.00410678	1	63	F	Sunitinib	Y
Xc59f11474e4e288c94b16010682b8f96	18.03696099	1	68	M	Avelumab+Axitinib	Y
X8bbe55f701b2cb1741c3c8d3fc3e5f6f	4.1724846	0	64	F	Avelumab+Axitinib	Y
Xa755249e1936fab43234f6197f086d49	6.965092402	0	47	M	Sunitinib	Y
Xd9e044356ada439e9bb8b532db358d22	16.65708419	1	53	F	Avelumab+Axitinib	Y
X142598966b9c6f373bd9f077689c67d8	11.07186858	0	53	M	Avelumab+Axitinib	Y
X680a33183fd78f2b9a08c97342f7a9b0	15.3100616	1	66	F	Avelumab+Axitinib	Y
X185c844f7285ea8ae7eff4047bf8e2e8	9.691991786	0	51	M	Sunitinib	N
X09a4c5313418bc448fa16ba847012a9d	15.24435318	0	58	M	Avelumab+Axitinib	Y
X5f6d56c13a1a7968d5c20cf44c9ed3d9	2.858316222	0	63	F	Avelumab+Axitinib	N
Xeea47674d745fb638f7ed5d517b8e220	15.3100616	1	51	M	Avelumab+Axitinib	Y
Xf8574b7124f7a3b9e886350b171a85ba	8.344969199	0	68	M	Avelumab+Axitinib	N
X5de3a983edc9aa39a8a090196504d7f1	2.825462012	0	65	M	Sunitinib	Y
X40e911a28e5b04b44b080cc04a5fd654	12.55030801	0	70	M	Avelumab+Axitinib	Y
Xe1b0f87c25889df31bc0fe76a68853b6	12.5174538	1	56	M	Avelumab+Axitinib	Y
X3ef2c818baf894824f17e0b6e2422256	11.07186858	1	59	M	Sunitinib	NA
X4c8bc6afa4b41d21c24cbd1f6acbf449	11.07186858	1	67	M	Avelumab+Axitinib	Y
Xcb607df67dd6bb88c5aae2ff65c485ee	2.792607803	1	64	M	Avelumab+Axitinib	Y
X09dfa3b617b555a9df17e99b40f9db89	1.215605749	0	61	M	Sunitinib	Y
X272fccee2682565378fb775496b50155	1.478439425	0	46	M	Sunitinib	Y
X9b233d12051942da673360eae83092bb	6.965092402	1	48	M	Avelumab+Axitinib	Y
X204ddf78ad407b33588fa54b11ec93fe	5.552361396	0	67	F	Sunitinib	Y
X4c53ca0da8a337cc85f13c6beee2f35c	4.1724846	0	69	M	Avelumab+Axitinib	N
Xa52b10d9515b8daf85f93fc3df9c321a	5.585215606	1	77	F	Sunitinib	Y
X1282a363cb519143621bb786e756e788	1.248459959	0	55	M	Avelumab+Axitinib	Y
X0266eeade6ca63ad927d85117f882655	19.38398357	1	56	F	Avelumab+Axitinib	N
X2b5f3fd2a90978b344fec39d51c54017	1.412731006	0	65	M	Avelumab+Axitinib	Y
Xfa9dc94d5b73817daa418a97c1645c1a	18.00410678	1	74	M	Sunitinib	Y
Xbb15b2459d7bf3d5515151f9de1e9756	19.38398357	1	48	M	Avelumab+Axitinib	Y
Xbd1ed66c2fd724c85f233574a890149d	13.9301848	0	48	M	Sunitinib	Y
Xa8b6d1f2ec25a6d9e19c3ebdbebe07c2	17.7412731	1	67	F	Avelumab+Axitinib	N
X8224b875993f51494672ed5edf92ea3c	9.626283368	1	63	F	Sunitinib	Y
Xc4b7b0ee94a4981e06e6d598a29bff57	16.42710472	1	69	M	Sunitinib	Y
X554f7b5a74e90e51d22efb03b2581225	6.997946612	0	40	M	Sunitinib	N
X40f0e24dd55565b8fabafb2e09eb6526	1.445585216	0	53	M	Sunitinib	Y
X578b112acdb7a280ee7a333abf958899	11.10472279	0	70	M	Avelumab+Axitinib	Y
Xa05d7892b8a58c890541ef76171d8139	12.71457906	1	50	M	Avelumab+Axitinib	Y
Xd8a98f3c034a61b3e4cd919898417385	13.86447639	1	62	F	Sunitinib	Y
Xc188b96b05bf78247e14a26fb7231ec3	2.726899384	0	49	M	Sunitinib	Y
X956b58c9f3bc9154ebccad2ff4dad365	2.825462012	0	60	F	Avelumab+Axitinib	N
X5f162dc7790e03b002ba75d5db05e0a9	2.792607803	1	63	M	Avelumab+Axitinib	Y
Xee16677b2ffe9e0e7d96098fa2c24767	1.412731006	1	61	F	Sunitinib	Y
Xa90a3aa39f672f2756323d3c2217e355	1.379876797	0	47	M	Sunitinib	Y
X5e3f9f5f902b6fa7420fac1e04a2559c	4.073921971	0	64	F	Avelumab+Axitinib	Y
Xd39e67062f2c834c707b85a43e564cd4	4.106776181	0	74	M	Sunitinib	Y
X54dd7db38d84c7317ac97ea0525ea9f8	4.073921971	0	51	M	Sunitinib	Y
Xf1ffe6ffb2047ae25a3a9938406edb89	6.965092402	1	56	M	Sunitinib	Y
X490b3aaf0b34d71712e894ca670bff00	7.030800821	1	53	M	Avelumab+Axitinib	N
X0ab7ff33e9730deabcef80d2cc91f9ed	1.314168378	1	63	M	Sunitinib	Y
Xc24c2d5c9e3fbe370b73035d1fe213ed	4.1724846	0	58	M	Avelumab+Axitinib	Y
Xdf88f47459cd3df812fb7460a83728da	5.420944559	0	59	M	Sunitinib	Y
X502dfff1180e1952d964196c8493633b	0.032854209	1	57	M	Sunitinib	Y
X607e127bc3f0f2741a16db6f4d381a3b	18.72689938	1	66	F	Sunitinib	Y
X84e83abd42afb7a8f9e890db309e939a	4.238193018	0	66	M	Sunitinib	Y
X34776a2e5d2a57256fbafb696a57dec9	17.97125257	1	53	M	Avelumab+Axitinib	Y
Xcac44b421f2becc20ee74493b10ee0b7	8.31211499	0	49	M	Sunitinib	Y
X46c3c80adf66dc80a778498311a1fac6	12.32032854	1	38	M	Avelumab+Axitinib	N
Xccb12de1235ae5fbeced36bc8d13e7e7	12.38603696	1	66	M	Sunitinib	Y
Xc0183c37a6bb780e64db1e0c9e3fa76f	1.445585216	0	48	M	Sunitinib	Y
X5249c43c8376ddd9ea109e43669e06e0	1.577002053	0	60	M	Sunitinib	Y
X65ab81a70a3884a528b4e080a7dda7a8	8.31211499	1	61	M	Sunitinib	Y
X0099d88de74c5734bc0323e6c531ce9b	6.932238193	1	61	M	Sunitinib	Y
X4188bd9ad1e2c2f2d6a429c29ec28532	11.99178645	0	63	F	Avelumab+Axitinib	N
X1096a9d28ca7950724a896867e729133	1.642710472	0	59	F	Avelumab+Axitinib	Y
X298d47047ef997bfd4c253dca2cc0588	5.552361396	0	49	M	Sunitinib	Y
X2202ed712481940f934cfb5812b743f3	14.71868583	0	63	M	Avelumab+Axitinib	Y
X1bdeccb61df1623412271e05874b0094	1.478439425	0	27	F	Sunitinib	Y
Xfb9f7ca2d7daad69473b1192db1d7c30	12.74743326	1	51	M	Avelumab+Axitinib	N
X0d5f6c7702aa2126719f1449869cb871	1.412731006	0	56	M	Avelumab+Axitinib	Y
X7633ae66d8c814f618ccf6a136fcb5d5	12.35318275	1	59	M	Sunitinib	N
Xe8e5271bc8c846a413d8a8738f7305c5	12.48459959	1	57	M	Sunitinib	N
Xedf05e441e14f691663cd2d1807276b4	8.344969199	0	64	M	Sunitinib	N
X54d26518c4a4300bbefa41c5a25040ec	12.48459959	1	63	F	Avelumab+Axitinib	N
Xf248a96e9f28c80844e8c27fc86d3e4d	1.938398357	1	60	M	Sunitinib	Y
X942564e2e36dccdd3abc6e3da165c8c6	11.30184805	1	72	M	Sunitinib	Y
Xb062ce653c73b5ff8a3ed1b0f3534651	2.825462012	0	69	F	Sunitinib	Y
X35d35932e2d72f1f42e28f89e8764de4	2.825462012	0	38	F	Sunitinib	Y
X62b6c7739d9d7e6d52985b4c46c4d00a	0.032854209	1	67	M	Sunitinib	Y
Xd25d93b78bd1e0867aad1aab4ff01342	6.932238193	0	52	M	Sunitinib	Y
Xf3c3723ca1a17b924a7637976d8a47a9	9.724845996	1	44	F	Avelumab+Axitinib	NA
X8e1ad2854c3bea90f66eef338b4f813f	8.574948665	0	64	F	Avelumab+Axitinib	N
X287b3d4433b74e09d38721f8c403f553	1.445585216	0	59	F	Sunitinib	N
X2120e95574229d89ab8e6890708ae502	10.18480493	0	52	M	Sunitinib	Y
Xd96588b7afb60fd88370d1f48bc427aa	10.61190965	1	65	M	Sunitinib	Y
X5a425ff0c21242dd543426597208a950	1.149897331	0	66	M	Sunitinib	N
X40ef60154637b182cec34180a7403f79	7.425051335	1	56	M	Avelumab+Axitinib	NA
Xc69e258f8fe7aab43915d72d4842bfd5	6.932238193	1	61	M	Avelumab+Axitinib	Y
Xd77c1f9d62e12082abb31e74d3c8d6df	7.195071869	1	65	M	Sunitinib	N
X452895fe0406e7693221f22e764560a2	7.326488706	1	69	M	Sunitinib	Y
X01b45623e3bb135c0446448c619c9e45	4.13963039	0	56	M	Sunitinib	Y
X64a237d7f7f6096638bfab20b7a0975b	7.72073922	0	60	M	Avelumab+Axitinib	Y
Xd15a6cf4a5cb803bad1e1018c3860868	20.862423	1	65	F	Avelumab+Axitinib	Y
X2d32545eaa2458ef0fb3f49222cf988a	17.90554415	1	65	M	Sunitinib	Y
Xa7b387551de3ed990e8439c16b16e051	4.13963039	0	54	M	Sunitinib	Y
X69e3512f7d6ff609c8b727e541e22187	3.909650924	1	72	M	Sunitinib	Y
X3e72c667849f46d12575de2c8fe1b73f	19.35112936	1	75	M	Avelumab+Axitinib	Y
Xfa8012d58e6e95476342cc3e0d7eefa3	1.77412731	0	60	M	Avelumab+Axitinib	N
X3e9285464b7e2890bf186db889d8df4b	11.03901437	0	66	F	Avelumab+Axitinib	NA
Xaf2bc83e78148af5d2a4ac4796d4f654	13.79876797	1	79	M	Avelumab+Axitinib	Y
X2111fa69962467ac3774495b34549ca8	12.48459959	1	61	M	Avelumab+Axitinib	Y
X5c8076eeca70f8a7c44e2a1693e31936	5.618069815	1	65	M	Avelumab+Axitinib	Y
X6a727ed3fd694e28e7e3c8df3dea219b	5.618069815	1	71	M	Avelumab+Axitinib	Y
X499855b171ee5626422214dedd2abe64	2.266940452	0	68	F	Avelumab+Axitinib	Y
X82e18c17d30609fcaef903843d59d791	12.84599589	1	43	M	Avelumab+Axitinib	N
X6304847204cc728b80efa8eb1290a69a	7.162217659	0	61	M	Sunitinib	Y
X556c48640c368af6f43a861cf738e3c9	12.48459959	1	62	M	Sunitinib	Y
X75cfd69ff98e0fa2a5db8989e77a57a9	4.1724846	0	55	M	Sunitinib	N
Xdae1b2a0bb4d7a946c6090f4b63ff3cf	9.856262834	1	46	F	Avelumab+Axitinib	Y
X467b481876db1758d9b38a75aabbccdb	2.694045175	0	64	M	Avelumab+Axitinib	NA
Xbe6871919074c89a4a134d2772f8b338	2.464065708	0	65	M	Avelumab+Axitinib	Y
X983637d5ccdddf029d4f1858eaef9527	17.97125257	1	70	M	Avelumab+Axitinib	N
X3d0e882f5ba9d8cd36fb62661a9f2a3e	5.585215606	0	50	M	Avelumab+Axitinib	N
X45b90f085077bf19a0687200420aad0a	9.757700205	0	62	F	Avelumab+Axitinib	Y
Xd5eae02dd41ea80edd57dd47b9c6fe61	6.997946612	0	54	M	Sunitinib	Y
X171f97d4eec5de4815cf607897a88f0c	6.932238193	0	60	M	Avelumab+Axitinib	Y
X1dba533b49b13d3dce87dcb185810486	5.618069815	0	75	M	Avelumab+Axitinib	Y
X5b169de75ba2f6ed26ba8a5e40e525f2	0.032854209	1	66	M	Sunitinib	NA
Xffe3f3ffcd97736a82990cc6f81078d3	18.20123203	1	44	F	Avelumab+Axitinib	Y
Xabf7e93504cc2e54f324e7fd1e7c5ae3	13.17453799	0	70	F	Avelumab+Axitinib	N
Xa0b271c0bf7021d54e2423c6cafdf7de	13.33880903	0	72	M	Avelumab+Axitinib	Y
Xe72293cda67b6d1dd148f3b67eaa122c	1.577002053	0	60	M	Avelumab+Axitinib	Y
X8052f165e6716be68da7dbcea1b38df3	6.932238193	0	49	M	Avelumab+Axitinib	Y
Xf8b4c97e1b0ad388dbcc1389a8c917d1	8.246406571	0	56	F	Sunitinib	Y
X38b2880ae87d19d8cd707816a01fe3b6	14.16016427	1	39	M	Sunitinib	NA
Xd7dd411b73b7259c58e59a119da0ba2b	7.852156057	0	56	M	Sunitinib	NA
Xef9793fca0e9a13cc375c53500e2d988	1.379876797	0	52	M	Sunitinib	Y
X1fe6a3a7f298df27824af9fb32a1f415	1.347022587	1	72	F	Sunitinib	N
X00892b2a96088ee5a09b881368c01fda	16.98562628	1	55	M	Avelumab+Axitinib	Y
Xc75f6b721a01befb3490288c36184505	1.314168378	1	50	M	Sunitinib	Y
X508809138ecda9e130efff4a8aa0a4fe	1.314168378	1	79	M	Sunitinib	NA
X4fa8e3d17fe0614389e39cf8cfcadbc7	15.17864476	1	59	M	Sunitinib	N
X0ad83b437ca02c81ce96b41431f58eec	1.412731006	0	40	M	Sunitinib	Y
Xc64192030a61c841728f4019d85f9c8d	2.792607803	0	64	M	Sunitinib	Y
Xa9b94b18beed8e4ee8bf626c2f41e756	2.792607803	1	63	F	Avelumab+Axitinib	Y
Xc9ec93cdf458fbc79be404feb57bb494	17.97125257	1	58	M	Sunitinib	N
Xce364e38e480eafe53540bf89440fe06	2.792607803	0	51	M	Avelumab+Axitinib	N
X2db4e193504ffaff309e95893fb2466e	5.552361396	0	49	M	Sunitinib	N
Xc5bda5244ebc014a1e9b8ec3b82ff609	8.31211499	1	66	M	Avelumab+Axitinib	Y
X8a140e4066fb9259506e894e021e10b9	1.412731006	0	47	M	Sunitinib	N
X5450a2f44a83967cee81bf8e9599ae30	1.412731006	0	61	F	Avelumab+Axitinib	Y
X32be66e8f559cffac728b3bc63ddeab7	5.585215606	1	59	F	Avelumab+Axitinib	Y
Xf3ac6f603238c11835fef887af6fb9c3	8.114989733	0	61	F	Avelumab+Axitinib	NA
X38fdaad447be4708ecd1a3b2ac1b7885	19.21971253	1	46	M	Avelumab+Axitinib	N
X571642d8d7710a3dee6da58737ae279d	8.147843943	1	61	M	Sunitinib	Y
X4e556b86ec1a151292f64ee0ce49e659	17.7412731	1	56	M	Sunitinib	NA
X3f1980268b36d427000556736ffe5ca0	17.83983573	1	52	F	Avelumab+Axitinib	N
X3f3a813569b26faf2170ec083721b75b	11.07186858	0	65	M	Sunitinib	N
Xf820ea17f0159aa56af9c0d10f5c329b	13.83162218	1	66	M	Avelumab+Axitinib	N
X35671922eaa1523f8aca598b03b2356c	13.83162218	1	65	F	Avelumab+Axitinib	NA
X3080ff5d464ab4f495f18195a79efec3	12.48459959	0	61	M	Avelumab+Axitinib	Y
Xe3eac6c3ae811b0f2d329190bcc32bfb	9.034907598	0	51	M	Sunitinib	N
X8c0e6d6daa5b513664fa5cb50f241ae5	2.825462012	0	57	F	Sunitinib	Y
X37c71ecb5064264c046feb617faba578	10.87474333	1	66	M	Sunitinib	N
X2670ad3a317ed910833dfdd6c8cd31a2	5.420944559	0	75	M	Sunitinib	Y
X41adc178a0c91e8182417308a2ead0af	1.347022587	0	69	M	Avelumab+Axitinib	N
Xbfc724a75b2df0ca789d38c68601577b	6.866529774	1	69	M	Avelumab+Axitinib	Y
X94aa5f458f7a31eb62a73261193902c3	6.242299795	0	73	F	Sunitinib	Y
X869639c8cf3ec578813dc01d0be68693	3.022587269	0	67	M	Sunitinib	Y
X576a2127247e20df85ed680ced8925f3	1.412731006	0	64	M	Sunitinib	Y
Xcdec14b3a2a262641b0df4d31bbf1ab0	2.825462012	0	68	M	Avelumab+Axitinib	Y
Xc5dc3cf7d7318a3b9972c13f9392a732	1.412731006	0	74	F	Avelumab+Axitinib	NA
Xdb0d336db224827a56359f1b1ea13654	12.45174538	1	68	M	Sunitinib	N
X99dbc837bfac39be482effb404028854	9.49486653	1	60	M	Avelumab+Axitinib	N
X3e5badf09c1f168d8e19efc1ebb54260	9.757700205	1	64	M	Avelumab+Axitinib	Y
X84f5b186b27d3e997f520464742b1e5b	2.661190965	0	61	M	Sunitinib	N
Xd0c1dc8de8036a8af7c08b5d06e3bf12	6.603696099	0	53	F	Sunitinib	N
Xce8e1f9255be02a2c8982aba865b90e6	8.180698152	1	56	M	Sunitinib	Y
X14bb75459fb5c1a32548e228da504349	6.833675565	0	68	M	Avelumab+Axitinib	Y
X7d4bc3496949fda54a71b36fdb6ce5fb	1.511293634	0	60	M	Sunitinib	N
Xa3e56cbd169a4c9417ba33ad4abb4f68	2.792607803	0	79	M	Avelumab+Axitinib	Y
Xb847a6787ab5c7701c641462787e3ac0	0.032854209	1	72	M	Avelumab+Axitinib	Y
X3cad782b3b82b0a0decac662d2c23ffc	2.98973306	0	50	M	Sunitinib	Y
X8cc1da58e4181fe5bc06b8bf8d61319a	1.544147844	0	76	M	Sunitinib	N
X4e87ea75ef4ec88b310fadbe64482350	0.032854209	1	66	M	Avelumab+Axitinib	Y
X53eba04ff3a0b1e2e6bda5cc55bab6b4	8.542094456	0	75	M	Sunitinib	Y
X48e13f7e3294458f4ec622516f632d11	12.68172485	1	71	M	Sunitinib	N
X4c5d2d4d935901608238afa354af9e31	11.00616016	1	73	M	Avelumab+Axitinib	Y
Xeb02b03986fb165db0918e780f07686a	5.585215606	1	63	F	Sunitinib	Y
Xc38497606b7996fc037b818f4e18d2e5	8.31211499	1	73	M	Sunitinib	N
Xed91741e1dcf7f5d6daa5266d106db68	8.27926078	1	63	F	Avelumab+Axitinib	N
X4e0cabea7a8fc8b2f393af82854d435e	8.673511294	0	83	M	Avelumab+Axitinib	Y
X2653cf815108af994cd80e56b46c6b66	6.899383984	1	45	F	Sunitinib	N
X2eaa54feaf4a758e6fe3495a9f3cbf0a	NA	NA	63	F	NA	NA
Xe0b1d98af1a2051f94a80e6d25ac90f3	18.62833676	1	65	F	Avelumab+Axitinib	Y
X31fa1e19b01dc9f394e3137d9233ac7f	1.478439425	0	68	F	Avelumab+Axitinib	Y
X0f3ebb55cb792f27d6b89dfadc958636	2.858316222	0	65	M	Sunitinib	Y
Xcc33070c83d7aee7287a6b209863d68b	4.928131417	0	58	F	Avelumab+Axitinib	Y
Xe3f5aefef52a59a32a563f27080f7718	4.435318275	1	66	F	Avelumab+Axitinib	Y
X7ba0880db058aca544b670e72cace7fb	8.377823409	1	65	M	Avelumab+Axitinib	NA
Xb77bf2b3a4da17962117b81d2daf46a2	8.31211499	1	54	M	Sunitinib	N
Xc89fc7348dd8c1385404fc2e54eb5dc8	8.114989733	0	50	M	Sunitinib	Y
X76ebb83ce08b46b79c0ac9188be50566	6.735112936	1	63	M	Avelumab+Axitinib	Y
X72d1be50f12b9e7518b7dee51a59d13d	11.20328542	1	67	M	Avelumab+Axitinib	N
X6348fa126256a61bee9a1ba9f1dfc580	9.49486653	0	65	F	Avelumab+Axitinib	Y
X5e1d0f6c1f49464de96f31fe97563788	8.936344969	0	78	M	Avelumab+Axitinib	Y
X0ccea5ff3169707a9e21cdac6235c894	7.12936345	0	64	M	Avelumab+Axitinib	Y
X6850853871fe7de4824940eb9c36bbd8	4.369609856	0	67	F	Sunitinib	Y
X72fb0792922d23f91b76941c00fae64a	2.924024641	0	51	M	Sunitinib	Y
X5407d51e6a1cd375921bc54e8e0007b7	1.412731006	0	59	F	Sunitinib	Y
X461c081c2c3c0af3a9064fe5bc520214	1.445585216	0	63	M	Sunitinib	Y
X20d133389892a705133675d732b26222	8.377823409	1	56	M	Avelumab+Axitinib	N
X50935f9214eebb9b48faaadfdded89f7	1.379876797	1	76	M	Sunitinib	NA
Xdfdd7fccd5034a7bd0a28edc779a6294	8.246406571	1	53	M	Avelumab+Axitinib	Y
Xa5a89e3b494c89531b85775c39b079bc	2.825462012	0	55	M	Sunitinib	Y
Xee20a06333f572a12339eb1f7194201d	5.683778234	0	46	F	Avelumab+Axitinib	Y
X352412f22a8f59acf459a2215d1ba92a	6.997946612	0	69	F	Sunitinib	Y
Xd0a1c785570866e67fda7b0c34acfd22	5.848049281	1	60	M	Avelumab+Axitinib	N
Xe33838348374cf6c65cb5a6baa2b4c4b	0.032854209	1	50	F	Avelumab+Axitinib	Y
X2aa31f4365d2e06f42bc23886ce71799	8.377823409	1	73	F	Sunitinib	Y
X310fe9b5581d300c56d4e083f62cd9c1	1.379876797	1	48	M	Sunitinib	NA
X805f226a799d96e3e9e9511d5bd6202e	2.759753593	0	66	F	Sunitinib	Y
Xf5a2059beeba6e31fba615d78216c585	12.45174538	0	60	M	Avelumab+Axitinib	Y
Xc646bb117ef7c10a0088395cac42ce55	0.032854209	1	54	M	Sunitinib	Y
X1faafa1d86ddce2725e2603243a8c37e	16.82135524	1	62	F	Avelumab+Axitinib	Y
Xd8f6729e866977119d019d4300085941	11.30184805	1	48	M	Avelumab+Axitinib	Y
Xd526d42acae6d1b12f5e30487a55e78d	1.412731006	0	53	M	Sunitinib	Y
Xd1a6fd738d0478743aee89fc13d7bcdf	1.347022587	0	28	M	Sunitinib	N
Xa287e74d0c158f8cbd802441931ecc07	7.162217659	1	65	F	Avelumab+Axitinib	N
Xd49b5e8094b1d830ee7c6da8f19fe307	4.238193018	0	63	M	Sunitinib	N
X398c18c873a0a6fed544ad1036ee9c5d	9.691991786	0	61	M	Sunitinib	N
Xd8558e573991e2971cf01260e1101676	5.618069815	0	58	M	Sunitinib	Y
X42556d0b960d68b60325a585a3fe5ffa	5.880903491	0	68	M	Avelumab+Axitinib	Y
X76d469653530f5fd2aedd5f9dd3e8fac	11.07186858	1	63	F	Avelumab+Axitinib	N
Xf570e8d959cc8b7b23a0a691f39b7ed5	10.18480493	1	57	F	Sunitinib	N
Xe512025f35a2c6d0ade6114bdf40ef79	6.997946612	1	75	M	Avelumab+Axitinib	N
Xc47444ad611f007560f0c1a76a2e7136	8.114989733	0	67	M	Avelumab+Axitinib	Y
X9457e7153bc0fd8705ef080016501d90	11.33470226	1	66	M	Avelumab+Axitinib	N
Xa3f38659711e7c28cb5e1ad6d4057479	9.691991786	1	51	M	Sunitinib	Y
Xd49637e55ceb4ffe81743fbe5ed0adee	8.31211499	1	61	M	Sunitinib	Y
X64de93bb26f4887edaf9e2a0dec979ce	2.694045175	0	75	M	Sunitinib	N
X80dd6edb18c222882a5790ea6cab9382	5.552361396	1	66	M	Avelumab+Axitinib	Y
X5aeeeeef22621c3fc5d7c32bbb338257	1.445585216	1	46	F	Avelumab+Axitinib	Y
Xe495d4d58d8a6ac92ad28d75abfa99ea	18.03696099	1	62	M	Avelumab+Axitinib	Y
X607e71afdc7087fd9311b272eab73044	16.72279261	1	67	M	Sunitinib	Y
X8705f785a45ba82a0bef7f7de48ac9dc	9.724845996	0	60	M	Sunitinib	Y
X65267ab96e97ada6d44778c6bca9c9e8	3.252566735	1	64	M	Avelumab+Axitinib	Y
Xe8558ecb11f1d75b941f56982a68ba5e	8.509240246	1	62	M	Sunitinib	Y
X641dbbe575a5f9409b270bd86a815b1d	4.1724846	0	48	F	Sunitinib	N
Xa7c0e70ae013f1426d039bd66de57f08	5.683778234	0	42	M	Sunitinib	Y
Xed99414f95c227f254fb0000c7ccc6cf	14.06160164	0	76	M	Avelumab+Axitinib	N
Xf339ed9120803df547c528b253ddca06	6.932238193	0	68	M	Avelumab+Axitinib	N
X6f4df463288b75e2feafcdbdf0a30299	3.022587269	0	58	M	Sunitinib	Y
X1d7f4d3ed5e4fa978c54baff3e53cdbf	1.872689938	1	70	M	Avelumab+Axitinib	Y
X490c18e70438680918d3ff4b611c6a0a	1.708418891	0	43	M	Avelumab+Axitinib	Y
X59b82f0ea6ca1faa0dc5ff2f15111ff8	17.97125257	1	69	M	Avelumab+Axitinib	N
X10130b561ceb11a8156178cc262a4103	8.246406571	0	54	F	Sunitinib	Y
X76ac22987ded8959b45ee5e35375195f	15.21149897	1	68	M	Avelumab+Axitinib	N
X08bfc83017b14d6fa292cd9ac8bd7385	2.661190965	0	52	F	Sunitinib	Y
X46a41725b121bf202d07031f3df99bf7	8.772073922	1	68	F	Sunitinib	Y
Xd26a56af9e989bd7a353d2c65db6fd51	15.21149897	1	55	M	Sunitinib	N
Xe8861b1bdcca5b3576f25986bd4e91df	4.041067762	0	54	M	Avelumab+Axitinib	Y
Xee2a62dcba6acc0d1bc069e60743412d	9.724845996	1	63	M	Sunitinib	N
Xfdb742505b30978af60b426c93a32f9e	5.585215606	0	67	F	Sunitinib	Y
X864e74fbe9ad79a4d7f9bd091ed43a5c	5.815195072	0	58	F	Sunitinib	Y
X5ff923bba9daefad54e8f268b0809fff	4.238193018	0	66	M	Avelumab+Axitinib	Y
X33ba1e8c2ebd0601d58598d409bbce02	9.691991786	1	76	M	Avelumab+Axitinib	Y
Xc04593b83b1751a2dd66ab95b283762f	5.552361396	1	64	M	Sunitinib	Y
X0391e4d27df3045469a1d1b9229eaca1	5.650924025	0	51	M	Sunitinib	Y
X39ab8beb38a6bbd1f266b227993a4ac1	0.032854209	1	66	M	Sunitinib	NA
X7d786118a14bb08daf7b5cad85f27371	0.032854209	1	52	M	Avelumab+Axitinib	N
Xc34326aa3930cff64eb1b7d41a118de6	11.49897331	0	52	M	Avelumab+Axitinib	N
X00f9c65e32de1453c94e179f97f944d8	6.965092402	1	69	M	Sunitinib	Y
X193f7ec30727febd61c08d29f0af0ba7	11.10472279	0	55	M	Sunitinib	Y
Xbd32d5ec6f302b0dd3ef0b0231735cfc	9.724845996	0	61	M	Sunitinib	N
X83ca17dfbc3af3ec0ae6f1ab539567e2	11.137577	0	75	M	Sunitinib	Y
X5192cc2d92465d8b0ba49312063db25e	12.38603696	1	73	M	Sunitinib	Y
X4f91a5db5911b40d50c2cc4a5859c5cd	2.792607803	1	56	F	Sunitinib	N
X1802823414b9dca9c0f602e38ce895cb	7.030800821	1	75	M	Sunitinib	N
Xc6a61f7c41e6a871d73d1ed7f3023bf0	9.330595483	1	40	M	Avelumab+Axitinib	NA
X7aab63b81cbca980182499c88a292852	5.650924025	0	62	M	Sunitinib	Y
X895f59cd352baa63d73afb1a9cfd7c11	8.542094456	0	64	F	Avelumab+Axitinib	N
Xbcad6ee2a417feef84e852817756b192	8.31211499	1	70	F	Sunitinib	Y
X1e10d10c2195f4d70c9ffd2ed3a719f8	10.61190965	1	78	F	Sunitinib	Y
Xeeaf49ce11a583158224e2bedccb0483	8.114989733	1	63	F	Sunitinib	Y
Xddfb6783c289302f8084934a25584284	4.13963039	0	46	M	Avelumab+Axitinib	Y
Xd1096f586abee776522c0b579dc5c77e	11.00616016	1	59	F	Sunitinib	N
X7a6b12f051db97d098b41ff41218419b	1.379876797	0	63	M	Sunitinib	Y
X7903b560c4fa52ba0200b068191bb1cd	1.281314168	0	61	M	Sunitinib	Y
X1b563e8c2c774da58f0ef669a2250dac	5.486652977	0	77	F	Sunitinib	Y
X3d46f788eb25894e1eb4b8159ecdf725	6.800821355	0	53	F	Sunitinib	Y
Xafff67ec9f0a450fcca0a36d7abd2a58	4.041067762	0	61	F	Sunitinib	Y
X6e6f5c96d10dfa96418a6e67218cb9b7	12.22176591	0	43	M	Avelumab+Axitinib	N
X75528f585fc35a72c1f7b575cc390ee2	2.726899384	0	64	M	Avelumab+Axitinib	N
X03016c67e1946ae7308df16f53345cfa	6.899383984	1	54	M	Sunitinib	Y
Xbdfa6222382f82a7f9b125c93057cc7b	5.552361396	1	74	M	Avelumab+Axitinib	Y
Xf701105a0919e5779993cf68c6ffbc2f	5.388090349	1	64	M	Sunitinib	Y
Xcaf75e13d2effba7208a0e31f770ba1a	12.48459959	0	48	F	Sunitinib	N
X1ba52a7abc319889dca25ff07f0b3415	3.088295688	0	66	M	Sunitinib	N
X056230ea2ba3882dc1829f3738510751	0.985626283	0	49	M	Avelumab+Axitinib	N
Xd08176f366ce640169b7758844c0bbfe	11.07186858	0	61	M	Avelumab+Axitinib	Y
Xc38a7929f06b5f518c563f80152a25be	1.412731006	0	64	M	Sunitinib	Y
X958ebbaef76f179c25a4b8a2dd03919f	9.691991786	1	65	M	Avelumab+Axitinib	Y
X2c2ff92bdb686414aa7bed3fce8ae0e4	9.724845996	1	58	M	Avelumab+Axitinib	Y
X5c5116e7958575e3f79c936efe1c57a9	2.825462012	0	51	M	Avelumab+Axitinib	N
Xd695bc17392990da03f89704a05de665	4.106776181	0	41	M	Avelumab+Axitinib	N
Xad0910eaf4bab626ae0dde5d6105c5b0	5.519507187	0	50	M	Sunitinib	Y
Xc0d740aee432540ab1f08253b480a0db	6.932238193	1	65	F	Avelumab+Axitinib	NA
X8301d6fe44fd03cc1af1d730ae7938e0	5.552361396	1	68	F	Avelumab+Axitinib	N
X244cbebbf7d53a5be4506f107e185b76	1.412731006	0	58	M	Sunitinib	Y
X7fce185da7ac24ba2e5cab56adf3a4b4	18.00410678	1	63	F	Avelumab+Axitinib	N
Xdb344673daa50c52bb374f4d04a405db	8.410677618	1	50	M	Sunitinib	Y
Xc8b258f1bece55ca2497e1e55ad7c280	5.618069815	0	73	M	Avelumab+Axitinib	N
X4ef84c59544ab1ec4571d9d3bc5bf20f	15.37577002	1	70	M	Avelumab+Axitinib	N
Xcb38f2905eeb732b3979a44c7c48cd52	6.965092402	1	53	M	Sunitinib	Y
X700ca99e57d59839d99783a77cc12478	8.147843943	1	56	M	Sunitinib	Y
X8e4df9019ca3ee5404c9476242ef30cd	7.030800821	1	66	M	Sunitinib	Y
Xe2365191520bb0c3c2fe29823c7ac4a8	0.032854209	1	88	M	Sunitinib	Y
X0d6dc6f04227c9e2d68b1bd2cee57be7	5.650924025	1	78	F	Avelumab+Axitinib	Y
X401be11fcf63b27f4108d070f0ff829e	7.030800821	1	69	F	Avelumab+Axitinib	N
X5b66f583d957f8c8d608dc06bd9cb022	2.792607803	0	56	M	Sunitinib	Y
Xac45c5f63593fb9b54d73e75ec6dca7b	5.486652977	1	77	M	Sunitinib	Y
X9b27f217bbbd8ff266ee15a4ce8da539	21.19096509	1	62	M	Avelumab+Axitinib	NA
X3a372fcb59ee94bc8b7ff7282169410f	20.76386037	1	52	M	Avelumab+Axitinib	NA
Xb7346b3bcdd53dc6b44090896d4b1e8e	8.31211499	0	65	M	Sunitinib	Y
Xec6d2ac4a9efeb327b23f4604d14de8d	4.205338809	1	56	M	Sunitinib	Y
X2c91f66dca78e448a837b6254bb8e805	9.724845996	0	49	M	Avelumab+Axitinib	Y
X98c979b09eea41ffff563b4e906fe515	8.344969199	0	63	M	Sunitinib	Y
X399e52bf5620e856a190f0f002599eef	4.205338809	0	63	M	Avelumab+Axitinib	Y
Xa3860b3957d9e15d05c4947503ea3c3a	0.788501027	0	70	M	Avelumab+Axitinib	Y
X4b75915eb3afa63070a7ccb9ce18e3ef	8.377823409	1	53	M	Sunitinib	N
X31a31f6f73350abb07e3ca22680fe24a	6.965092402	1	46	M	Avelumab+Axitinib	Y
X325990935719891410e512c206130909	0.032854209	1	66	M	Avelumab+Axitinib	Y
Xb568ca553ada1a11e6e4283e2426a605	0.032854209	1	67	M	Avelumab+Axitinib	N
X36d6f54c18a77130f8598458b0539ea2	1.478439425	0	68	F	Avelumab+Axitinib	N
Xc22352bcf84a24c5c7629686d3b31ca4	2.759753593	0	40	M	Sunitinib	Y
X10cac65fe934644120fb592381042cf1	7.162217659	1	58	M	Avelumab+Axitinib	N
X16f59d5c4921b2ba45f007dabad3cbed	2.628336756	1	79	M	Avelumab+Axitinib	Y
X6db065de288cb9dbb118cc972e93110a	5.552361396	0	56	M	Avelumab+Axitinib	N
X593569c497e958a1d11e78c30aa495e1	9.691991786	0	51	F	Sunitinib	Y
X707562e580c4531bd64bdb40a77599f0	5.35523614	0	69	F	Sunitinib	Y
X8e828e2c0cf2d1a5a910a8b0fc286651	6.275154004	0	68	F	Avelumab+Axitinib	Y
Xd7996586134d83e7ec1fb0ef138a8681	1.248459959	0	54	M	Sunitinib	Y
X7c31805a23583362dc8ada543ae0bd69	5.782340862	0	57	M	Avelumab+Axitinib	Y
X9718340b6883560b297085e4d4eae2c0	2.726899384	0	66	M	Sunitinib	Y
Xc8aab3f0a71859b744be62893ffbfc78	17.97125257	1	57	M	Avelumab+Axitinib	Y
X8416e64212e80b7cd4da93491bccd1c2	8.213552361	0	37	M	Sunitinib	Y
X527f2aafe7403452b1f14607425ef28a	12.45174538	1	42	M	Avelumab+Axitinib	Y
X1315562a66350bf6495683fbbd32d811	11.07186858	1	58	M	Avelumab+Axitinib	Y
X7463814036931e491c4a97bf6135e87d	1.379876797	0	60	F	Sunitinib	Y
X2237594dd2d203eba67a604e1bb2e744	16.6899384	0	67	M	Sunitinib	NA
Xdc8850b7a6847a8b4e0302d3deb21746	11.07186858	0	73	M	Avelumab+Axitinib	Y
X21079996d2de38042f8100eff6d35591	1.445585216	0	55	F	Avelumab+Axitinib	Y
X5713a01986a6dad5bf423d25d7d78152	8.410677618	0	48	M	Sunitinib	Y
Xa50471a78f18e3f9fab10d9384a8422a	18.00410678	1	38	M	Sunitinib	Y
X3e50db01e03c1bc740cd746bcccf2dcd	0.624229979	1	69	M	Sunitinib	Y
X61a97d2741939f321db9d23e8ec3eb56	5.552361396	0	47	M	Sunitinib	Y
X26b8165c5fd1b2978e32af004874b1fc	1.412731006	0	53	M	Sunitinib	Y
X132b491d0edd4e1494250a18a31d442f	9.691991786	1	57	M	Avelumab+Axitinib	N
X4617a52675559f7b992cf596a448804f	9.691991786	1	50	M	Avelumab+Axitinib	Y
X611a08271d3957417656c975a6b9d37c	4.1724846	1	69	F	Sunitinib	NA
Xcd7226eabfc7461ac437f800e24ad62d	4.205338809	0	41	F	Avelumab+Axitinib	Y
X6f4813ac3666d0bcab8c61a8ac6bec57	6.932238193	1	68	M	Avelumab+Axitinib	Y
Xee4eaa5d3cc7dfb5f7a692bda987550e	5.815195072	1	54	M	Sunitinib	Y
X8c9cc36edfa940e108e6cb945f72fd5d	17.93839836	1	51	M	Avelumab+Axitinib	Y
X22f627bf28a75b163bb5e63e7b57930f	13.79876797	1	65	M	Sunitinib	Y
X804bc8010995f2c259ceda31d59510e1	18.0698152	1	60	F	Avelumab+Axitinib	NA
Xce948e7d8db414c6f2b3f1e5b592c9bc	0.032854209	1	35	M	Avelumab+Axitinib	NA
X65641b34493702375ff43aa39037a3f6	6.899383984	0	53	F	Sunitinib	Y
X2275eb9b1099f7bba3c04410aeb23019	0.821355236	1	83	M	Avelumab+Axitinib	NA
X5cb4498c894563eb4e95ed48fa91c130	1.412731006	0	39	M	Sunitinib	Y
X1efc2cb2e2d1bc514133aa8e649356c5	4.303901437	0	61	M	Sunitinib	NA
X88c4a2b57da8f599c2c8e2a6f7684a4c	12.45174538	1	57	M	Avelumab+Axitinib	N
X36a5cb9019e6b2362a0135c1909a8570	8.377823409	1	64	M	Sunitinib	Y
X774bdabe56f84b6a22415df31683f23e	11.30184805	1	82	F	Avelumab+Axitinib	N
Xfe945d5a8d7ac889ea4ec4a5c612fbb7	0.032854209	1	60	M	Sunitinib	Y
X3437bfdabe0e2ac65dd8374a5015bded	14.06160164	0	62	M	Avelumab+Axitinib	N
X13181576c8d17b661499a05d62cc4355	12.45174538	0	54	M	Sunitinib	Y
Xebda0643a03f2b2a2bd5e31289d3364f	13.86447639	1	62	M	Avelumab+Axitinib	Y
X8325a78d718bc670b1316f22f4e85e98	0.032854209	1	56	M	Avelumab+Axitinib	Y
Xadf18fcf9785e2da066871172f96624a	1.609856263	0	67	F	Sunitinib	N
X3695ccb568ee5ade84fccd8922563295	1.642710472	1	76	M	Sunitinib	NA
Xd7a5110c1873d5a085abe247c80cfb2a	5.585215606	1	69	M	Sunitinib	Y
Xcbdb3a4eba82ff552cf858d0d11a5947	1.445585216	0	49	M	Avelumab+Axitinib	Y
Xed96e2beaf054995261dde46f7eb024f	18.56262834	1	56	M	Sunitinib	N
X6849fd2eff84ed773898135a08c27c0e	2.891170431	1	81	F	Sunitinib	N
X26e514929c0ff7fae17a551d21ab46b5	16.59137577	1	73	F	Avelumab+Axitinib	N
X535d3b099f0a293a5d6b4bbd7b0f0e77	1.642710472	0	80	F	Avelumab+Axitinib	Y
X4a8c1f735194d39e533317527bf027cd	9.823408624	1	60	M	Avelumab+Axitinib	Y
X1dde58fa912bb474be7e9bea10cdb6a0	7.162217659	0	52	M	Sunitinib	Y
X110d6332f1947ee768bfd1a6473a1d8a	1.412731006	0	54	M	Avelumab+Axitinib	N
Xa8fc8e6f00eaf0bec86fe9ec2acb048c	5.585215606	1	64	F	Sunitinib	Y
Xd958f79f90ef2a70eaf9711208600728	5.223819302	1	52	M	Sunitinib	Y
X8d0423de9b5b093cd0f8a2c432c45122	10.84188912	0	66	F	Sunitinib	Y
X56ba97ddae593a006b800fcb28bbecd4	12.1889117	1	59	M	Sunitinib	Y
Xd38da66e6c76cebf440888b81e0bbbad	5.32238193	0	58	M	Avelumab+Axitinib	N
Xe0fe1687882ea27f858b471e27fda2af	8.082135524	1	66	M	Avelumab+Axitinib	NA
X974cd143fdd3a317f20044ea2cf0a5ce	8.049281314	1	66	M	Avelumab+Axitinib	Y
Xf9d1704261fa366e71727842483a4061	16.39425051	1	67	M	Avelumab+Axitinib	Y
X5916efe7b832a74bf5742f96d188463d	5.552361396	0	60	M	Sunitinib	N
Xa602de7454fc0b3169d3e7a6eb4accb3	15.34291581	1	65	M	Avelumab+Axitinib	Y
Xdda232ea154ef4752c1210c4cf0bc8f2	15.14579055	1	66	F	Avelumab+Axitinib	N
X1960e9013b7333ec0441b7298f2ac085	9.691991786	1	76	M	Sunitinib	N
X65379a04244f2cf660c1af93c36109e8	1.314168378	0	49	M	Sunitinib	N
X7d750305b45f45f2026be11e74fafcc5	2.628336756	0	70	M	Sunitinib	Y
X96bb5c571e081ceacfc6ecaef0f06eb4	10.87474333	1	73	M	Avelumab+Axitinib	Y
Xb6b7cad566ae32216898aff50bbd861f	11.07186858	1	48	M	Avelumab+Axitinib	Y
X6b8c28fe3354c91299dc9b4c9a40fb12	5.585215606	0	64	M	Sunitinib	Y
X823c84d42f579bb27c7602f09078d29e	1.248459959	1	73	M	Sunitinib	Y
X9d0c399b3ad78757f9188bd6aa785dc1	16.52566735	1	68	F	Avelumab+Axitinib	N
X9313a28c5ebcf8a326c4d9e965e31f84	13.83162218	1	68	M	Sunitinib	N
X55a61dec5a3418c9268f5f0e96db1aae	0.722792608	0	45	M	Sunitinib	Y
X69d338fa4daaa5f34396b8628481c825	8.246406571	1	71	M	Sunitinib	N
X4339d16f35631e6529cf5b7f6fead580	8.31211499	0	47	M	Sunitinib	Y
Xa5a858b323179fad90c5d0b860b8a8e7	11.10472279	0	66	M	Sunitinib	N
Xafe1b6e1c8ed32897fe1ad56489df744	1.412731006	0	58	M	Sunitinib	Y
X931ae2ec7ce29c4bd4e00c0c31777813	4.205338809	0	70	F	Avelumab+Axitinib	Y
X7bc580a9f4de797a0c875c62bd31ec83	10.90759754	0	74	M	Sunitinib	NA
X7c98f8edab0e202814e32c1c7c20831f	4.1724846	0	52	F	Sunitinib	Y
Xce9f25e180783082c9c095ea5dd0bda7	9.921971253	0	68	F	Avelumab+Axitinib	N
Xa60295fff4bd14b827f9ae56b53bce3b	10.15195072	1	70	F	Sunitinib	Y
X1acab56e6d9b6d862a0060dd370d6a20	0.131416838	0	61	F	Avelumab+Axitinib	Y
X396646fbe77614b1d94c8b579540c9e5	6.965092402	1	58	M	Sunitinib	Y
Xdbc72bd3fa34e684b07e70fe883e8624	1.511293634	0	53	M	Sunitinib	Y
Xe5708fa8dbb23ffce9d768f2af036bc8	9.527720739	1	67	M	Avelumab+Axitinib	Y
Xb4520634503998faccfd85cd4d83eb70	1.347022587	0	66	M	Sunitinib	Y
X48c1d034956d2932857a406c8dd2f945	9.691991786	1	70	M	Sunitinib	N
X8080e7abcb2fac011679a0f14fa28678	6.078028747	0	59	F	Sunitinib	Y
X318d71e76bc04ff80504fdeccd6bd06c	5.749486653	0	61	F	Sunitinib	Y
X883dfe26a92f2d337c082020465b08d6	6.899383984	1	71	F	Avelumab+Axitinib	N
Xd31100eb671fbd563ef499d02b7fc4e6	5.585215606	1	58	M	Sunitinib	Y
X027696d8647633ff2158827b4bfad8f6	0.032854209	1	59	M	Sunitinib	NA
Xb241a7f8140a03bfc5d8fd0fc2ede730	12.48459959	1	70	M	Sunitinib	Y
X70c8e245754792089b6d06c83b448e30	0.032854209	1	60	M	Avelumab+Axitinib	N
X10652087db64ebd98514dd0a2d33ec27	11.137577	0	69	F	Avelumab+Axitinib	NA
X5533e4b9ab4293e76c613428d49ed7f9	1.445585216	0	69	F	Avelumab+Axitinib	N
X7725ac4bf4b4ef6da024ec4830c6487c	7.162217659	1	72	M	Avelumab+Axitinib	N
X819edaadb358fdba6f7197b8f3cd3c28	7.162217659	1	55	F	Avelumab+Axitinib	N
X2b7d4d6de56baefee20232a28ff72b05	4.402464066	0	58	F	Sunitinib	Y
X07ac42d906a1d733d74eb512d16373e9	6.932238193	1	55	F	Sunitinib	Y
X87f909dd661a6f016797819f498c2cad	6.932238193	1	64	M	Avelumab+Axitinib	Y
Xc98150517e6c53b6d6dc9f7b76484e46	1.412731006	1	66	M	Avelumab+Axitinib	Y
X7f03ffe319d51d8c94516a53caf7b5d2	4.402464066	0	68	M	Sunitinib	Y
Xd8444f83fbf95c66164fdf3bd6355354	4.1724846	1	77	M	Sunitinib	Y
Xca567d7ce764e9fb0087e435220c2e70	9.757700205	0	43	M	Avelumab+Axitinib	NA
Xed54551bb947d2c743a518fc051967a4	8.27926078	1	55	M	Sunitinib	N
X90b83220b53c76c8d4970330a1fe882b	7.09650924	1	48	M	Avelumab+Axitinib	Y
Xebd60f0b53f631b3652393070ae27ff6	5.650924025	1	41	F	Avelumab+Axitinib	N
X8ce8d5e386619f67fd48550448a52b05	9.757700205	1	81	M	Avelumab+Axitinib	Y
X5153865bee65ce6bf758ce935fbbbcaa	6.932238193	0	49	M	Avelumab+Axitinib	Y
X390683a6edc8b1142d2fd26d8591f06b	6.932238193	1	61	M	Sunitinib	N
X3d7a2306f65da61f077afe15977ef9f5	9.232032854	0	64	M	Sunitinib	Y
Xf4296b0604c8d0b2a800837ada09ac5e	6.735112936	1	53	M	Avelumab+Axitinib	Y
X5cabb9f0afcc6ec89f28a72e66b75c5b	3.909650924	1	68	F	Sunitinib	Y
X80e9754208c8276033c7a0a2853360db	2.792607803	0	56	M	Sunitinib	N
X73188395f4e7518bb98a3f904ee10e2e	2.759753593	0	57	F	Sunitinib	NA
X5c36fc9c9190e8ef6f5ac745da99a844	1.544147844	1	77	F	Avelumab+Axitinib	N
Xa1ee7a84d356cfe587555a3c4ee15b67	10.87474333	0	53	F	Sunitinib	N
Xc762d8a2e994aba60b9538b732bbb037	6.735112936	1	72	M	Sunitinib	Y
Xe2f05dd9123c59886e6de8a27a9d7492	2.562628337	1	54	F	Sunitinib	Y
Xb983bac0b13161192f9db4ad92aeba52	5.32238193	0	46	M	Avelumab+Axitinib	N
Xe38d274b6db8d5529cc013942f95673d	5.618069815	0	59	M	Avelumab+Axitinib	N
Xe31f8279366dc42f3f3f3d98acfd4937	8.344969199	1	68	M	Sunitinib	N
Xdcd636f14733dd9befa590c3270f9c8d	0.558521561	0	67	M	Sunitinib	N
Xad4ca43e0058c9e288144acaaabc8ab4	7.09650924	0	65	F	Sunitinib	N
X5db2ba740f908fe3a3e6832d48949346	1.412731006	0	51	M	Avelumab+Axitinib	Y
X3d2cbfd8c3343515af2039db17d13b07	4.1724846	0	49	M	Sunitinib	Y
Xd30aeaed198995f5cfddc9e5c1114017	13.79876797	0	67	M	Sunitinib	Y
Xc3506d578907bd6af24e8b2b99ab5147	8.31211499	0	41	M	Sunitinib	Y
Xdc3586621e269f12c26d9218701db749	9.856262834	1	76	M	Sunitinib	N
X149d7097a5e30cd7e236fbb36d673c85	6.702258727	1	64	M	Avelumab+Axitinib	Y
Xc2d4165846f97640572ca02893698074	4.13963039	0	71	F	Avelumab+Axitinib	N
X1f84f6b509d18e2f0b94bfaa22379d38	1.281314168	0	66	M	Sunitinib	Y
Xfa5161da02dc708956db10f2f6d5962c	1.379876797	0	58	M	Sunitinib	N
X423d4e701b61d84a699cbabf6ffbb184	5.158110883	0	56	M	Avelumab+Axitinib	Y
X375ee2d507a784beb169bed5ad0005bf	5.880903491	1	58	M	Sunitinib	Y
Xf772ea4ed61813a59910f6c26332fa25	9.889117043	1	70	M	Avelumab+Axitinib	Y
X4b472c39d871e66c9dd202f62ee109fe	2.924024641	0	64	M	Sunitinib	Y
X7bc7d5df0739f7dd4d7f142c858971ff	11.30184805	1	79	M	Avelumab+Axitinib	N
Xc93021d3938abd806b6edb9e48982d3e	9.823408624	0	62	F	Avelumab+Axitinib	N
X6ae495b09cc60d421ca35e96b8617a78	0.032854209	1	73	M	Avelumab+Axitinib	Y
Xcdf653d491c2b7b8955f49f52e6cfafd	11.17043121	0	58	M	Sunitinib	Y
X84b76cf406160a69f3c0ca47a6f5fb33	17.97125257	0	64	F	Avelumab+Axitinib	N
Xa7e40154bb3957e5d149cb5459f9bb32	9.921971253	1	63	M	Avelumab+Axitinib	Y
X4fd2a06a93591162de642a421b33fa77	6.932238193	1	61	M	Avelumab+Axitinib	N
X62cfa3d54c2122ccae3ea722cb24dcbf	5.486652977	0	42	F	Sunitinib	N
X843b6d9d38faa538b6fca3ef0ce45d90	5.585215606	0	60	F	Avelumab+Axitinib	Y
X2081800a596560bc3d8396c000d5d288	4.1724846	0	78	M	Sunitinib	NA
X985dd445ee5348ce31d484e322cbfe35	13.96303901	0	67	M	Sunitinib	Y
X70d85275acf86d8a3299e613e53a4181	3.252566735	0	61	M	Sunitinib	Y
X68fa64ddcd99e95b6085b3ef1eb075b7	15.21149897	1	62	M	Avelumab+Axitinib	Y
X6f87d2548fe2b5dc86c417dc9a6be7e0	1.511293634	0	62	M	Avelumab+Axitinib	NA
X579077fd3e63881af9f41eafa31dc3da	1.347022587	1	73	M	Sunitinib	NA
X36938f2301d2f36761850f40c6e72f0c	4.1724846	0	56	M	Sunitinib	N
X488eabbc80a89d1e04993559f6ae9384	8.31211499	0	66	M	Sunitinib	N
Xe7bfaaf99f0a66c602b860c50f9bad60	8.377823409	0	76	M	Sunitinib	Y
Xb3397e408ae209f5d0b03e79954b0287	1.445585216	0	43	F	Sunitinib	Y
Xf2b2ecc54b302907b1020d1e1050e97b	11.10472279	1	67	M	Sunitinib	Y
X6c822e20f412da5f66e15ba09d63658c	5.848049281	0	63	M	Avelumab+Axitinib	Y
X6307d29e7ebc03887e7a9d4f0c39e56e	2.858316222	1	59	M	Sunitinib	Y
X692d529911641ea34c920a70eafac71c	6.899383984	0	58	M	Avelumab+Axitinib	N
Xdd6804845cff0c433823a2b25c480f2f	14.02874743	1	63	M	Avelumab+Axitinib	Y
X250f772f27a65f5113a1d499343c548a	12.8788501	1	56	F	Avelumab+Axitinib	N
X9b5f88b07a649863eb84fb80d727c11a	5.190965092	0	39	M	Sunitinib	N
Xca8fadcc3339337709f71b79464a83ad	5.519507187	0	60	F	Avelumab+Axitinib	Y
Xc67dcab848b11b0d17028de530d76677	12.61601643	0	69	M	Sunitinib	N
X33cc64b4735bf365bc230704691090a4	12.61601643	1	67	M	Avelumab+Axitinib	Y
X5eec42ac3d60e17a0ee801790e5f8c1a	12.48459959	1	66	M	Avelumab+Axitinib	Y
X7046afe6d8678450241140d66814922b	11.137577	0	46	F	Sunitinib	Y
X2ff0243ee6560db47ce501526b55fafd	11.43326489	1	63	M	Sunitinib	N
Xb1b6e68ddf4e7f59f6246de37b52a657	11.40041068	1	60	M	Avelumab+Axitinib	Y
Xa0573da176061e2b5b3f6cda5c46cd76	1.412731006	0	59	M	Sunitinib	Y
X95de3a9a466261563ac56429650618d3	9.856262834	1	63	M	Avelumab+Axitinib	Y
X8920cd6e9b1c09ec387519d700e0416c	6.800821355	0	56	M	Sunitinib	N
X02d38608a5177d4432002c2a9cf9751b	6.735112936	0	37	M	Avelumab+Axitinib	Y
X191913a7fe9b4af030fbc7e6c700a947	6.800821355	0	63	M	Avelumab+Axitinib	Y
X66fb3a3749cd97b35532ab29da0b434c	9.659137577	1	50	M	Sunitinib	Y
X06ef28ca7f0c2f30d845e89f85369f2e	3.022587269	0	65	F	Avelumab+Axitinib	Y
X49adc7734a3f2ce5accc83d55de64009	4.13963039	0	64	M	Avelumab+Axitinib	N
Xfdb20a7f909fccc82f69a598e0812a05	8.542094456	1	67	M	Sunitinib	N
X4bd202ebc23a5dbfbe179389ef540f31	6.767967146	1	75	M	Sunitinib	Y
X372d9a0fb462df93f8fb37eb775181de	6.735112936	1	51	M	Avelumab+Axitinib	Y
Xdc8b221d5d6d4dfb8ac4d9aeb748a1fc	1.314168378	0	66	F	Sunitinib	Y
X4f9df56534f76c8368d55ad18e5e7db8	1.347022587	0	68	M	Sunitinib	Y
X8e2d227961ce2739dd10b141b5e7ebe1	5.650924025	1	55	F	Avelumab+Axitinib	Y
X15919dea2971016d761675ebba619c41	0.262833676	0	75	M	Avelumab+Axitinib	NA
X68dabd574f9a4971ccd58ed239cde778	6.373716632	0	51	M	Sunitinib	NA
Xaf7263b2c6a6d79146ee2433c9097859	5.552361396	1	60	M	Avelumab+Axitinib	N
X844c374fcfa09eb8af0f5d4a1d7ec915	1.445585216	1	74	M	Sunitinib	N
X27afcfacd71eee5aa4442e362e09d8d3	18.13552361	1	44	F	Avelumab+Axitinib	Y
X8bd3ad55b8f72e406430d3ea0fd79497	13.99589322	1	60	M	Avelumab+Axitinib	Y
Xf24767fc3f98454a31fb773c39bb3d05	13.86447639	0	61	F	Avelumab+Axitinib	NA
X897660095e14291476c04c07d62ab19c	12.58316222	1	61	M	Avelumab+Axitinib	Y
X634bf443a76471fa32212f6537b66494	16.49281314	1	50	M	Avelumab+Axitinib	Y
Xe60a38f89d5f9bf4c9c5eecacb281bda	17.77412731	1	56	F	Avelumab+Axitinib	Y
X7a1f2bd4d9c59c579470b59b2cc5aef1	4.205338809	1	83	M	Sunitinib	N
X5b40b2b5588645ecf1b152f07b2156fb	2.858316222	1	53	M	Sunitinib	Y
X17c5b25010ace8eb555695a0f17d8058	3.843942505	0	57	F	Sunitinib	Y
X4a704854ae6f0adfea5e7e9d07d856e1	0.032854209	1	75	M	Sunitinib	N
Xe349b3b57901898f4ce19e0f8ae00073	12.25462012	1	60	M	Avelumab+Axitinib	Y
X4dc5526f2380d1944c16c405492293d5	10.87474333	1	67	M	Avelumab+Axitinib	Y
X307540b071972183f79089bf2968194e	2.595482546	0	71	M	Avelumab+Axitinib	N
Xcdad1e23d1a0bddec76b02dac62575ad	8.180698152	1	58	M	Avelumab+Axitinib	Y
X263dec8c8985ba77025d85703f19362e	8.147843943	1	55	M	Sunitinib	Y
Xcaa0f52a8bb4137e8f2d9f1dbab46f95	8.114989733	1	60	M	Avelumab+Axitinib	N
Xfda5067579ca1dbe0105f0044c9a1a36	1.051334702	1	58	M	Sunitinib	Y
X98f49d8e7e9e23332daa59a1736513b1	2.792607803	0	53	M	Sunitinib	Y
Xa86c464d7742799bc7cca15e5073ba6d	10.94045175	1	69	M	Avelumab+Axitinib	N
Xe49744bb3cd2750dacc5f87e48c34c34	8.27926078	1	74	M	Avelumab+Axitinib	Y
X40ff97e3fb95317c43e78c54e4af6fa2	5.552361396	0	63	M	Avelumab+Axitinib	Y
X4a725ce8104664f9c3a0e9d8b559cc9e	12.41889117	1	66	F	Avelumab+Axitinib	NA
X407f1a2a5483e7c610000f4a7d6626b8	6.965092402	0	75	M	Avelumab+Axitinib	Y
Xc3a87c39d5e5fd936c2cc6c2f40d1ac7	6.932238193	0	60	M	Avelumab+Axitinib	Y
Xec1bc98eaf9528b4671b2e6380ef1f7e	5.585215606	0	55	M	Avelumab+Axitinib	Y
X61ce42886ed83ef5b9e7113331d551b2	5.453798768	0	56	F	Sunitinib	Y
X50a360052d5f832029f99bcfc8d51b74	6.932238193	1	57	M	Avelumab+Axitinib	N
X6b4601894f962cfe4ff771b2a788bdb5	5.519507187	1	66	F	Avelumab+Axitinib	Y
X3feac9dc8f5e975c5141ac83fc438ea2	8.213552361	0	79	M	Sunitinib	Y
X3b1ff3ab3d1f98e94f9966b350d2d64e	5.552361396	1	52	M	Sunitinib	N
X9190ab7e874737a2b5ced7e7c83b037a	0.032854209	1	88	F	Sunitinib	Y
X780cfa362fa0dc62086edbc2b2114ba2	5.979466119	0	47	M	Avelumab+Axitinib	Y
Xa212833e830fba62ac4a50af668150c7	17.97125257	1	68	M	Sunitinib	Y
Xc9ec2d2ab166885e61b8c47662eb3867	8.509240246	1	68	M	Avelumab+Axitinib	Y
Xab2c4c91b315465a99537d47cfeb7ca0	13.83162218	1	57	F	Avelumab+Axitinib	N
X06c76fbf2ede7672b6d7ee8c254f3277	1.18275154	1	44	M	Sunitinib	Y
Xc2bbe39a40e0ea262e6d0b9d6ab7abc6	18.69404517	1	60	M	Avelumab+Axitinib	Y
Xf595addaf738129542c61ecbd2daa940	12.41889117	1	71	M	Avelumab+Axitinib	Y
X46e95b59369d11f455e586e0c01690de	1.379876797	0	45	M	Avelumab+Axitinib	N
Xbc08a17e9b687750725db0986f4dced2	1.412731006	0	56	M	Avelumab+Axitinib	N
X6c02f2b6404b5b719a0646c07f4a3479	4.13963039	0	71	F	Sunitinib	Y
X19ea89697b4c64446d8b8966fd09dd1a	9.724845996	0	60	F	Sunitinib	Y
X3d10e0a977bfcf7a76400414c51326d6	5.552361396	0	79	F	Sunitinib	NA
X5e2a6595a0b41b314d53bf750ab4e90e	9.593429158	1	69	M	Avelumab+Axitinib	Y
X2cddd57246691bb4967fd526e468af6d	9.691991786	1	65	M	Avelumab+Axitinib	Y
X368988fadc32836bcbde9f0d3ee487ec	1.577002053	0	43	F	Avelumab+Axitinib	N
X41ad534f4bc16a8535415c0f2e2fda50	8.31211499	1	57	M	Sunitinib	Y
Xec24d41a56b0f088acec71faf67921a2	1.248459959	1	43	M	Avelumab+Axitinib	Y
Xdbf4b0114f0ccc6c53724809d4946d8f	5.420944559	1	62	M	Avelumab+Axitinib	Y
X2528a2fb7cc4f5bc3922038fe45ba025	18.0698152	1	40	F	Avelumab+Axitinib	N
X723d15a0e582e2096f38afeeda3a18d0	0.032854209	1	72	M	Avelumab+Axitinib	N
X0ea4fd4766c95061896a4d66fc1db638	4.303901437	0	55	F	Sunitinib	Y
Xf530811b226c90782cb8ddd71e28cfce	7.425051335	0	51	F	Avelumab+Axitinib	N
X7c276f502728f99d72029bdb8570114a	4.205338809	0	59	F	Avelumab+Axitinib	Y
Xeb3456819968e1e488e594986af7fc23	3.909650924	0	52	M	Avelumab+Axitinib	Y
Xcdeadba663a471057fd7ce97bb34b3e1	5.650924025	0	63	M	Avelumab+Axitinib	N
X94cd280620f5e23ebcc4a2122ed7e243	5.585215606	1	60	M	Sunitinib	Y
Xba314ebdbc21a67b2f5a30ea871c1121	18.1026694	1	58	F	Avelumab+Axitinib	Y
X4434839d8caca6a0d57b8e0f2ca331fc	12.25462012	1	39	M	Sunitinib	Y
X065cba0a7be42c63bc66381248079786	4.369609856	0	72	M	Avelumab+Axitinib	Y
X892f6420e8654725d5e4285fecd01357	4.205338809	0	64	M	Sunitinib	Y
X1419bb61cff4470103db9366a61b6ad1	2.069815195	0	65	M	Avelumab+Axitinib	N
X55a53755c5d27e22e4408e44d1bc989a	4.303901437	1	47	F	Avelumab+Axitinib	Y
X464daad68082ebb8209ea5db3a50e7ac	1.511293634	0	53	M	Avelumab+Axitinib	N
X8b16dabb218e165eb22f3ae7d5fc2fe1	20.69815195	1	71	M	Avelumab+Axitinib	N
X664e3c39989d204caa88811baaad4e67	13.76591376	0	33	M	Sunitinib	Y
Xa1be8162bfc18fef3ecf0aa3de28f948	8.344969199	1	63	M	Avelumab+Axitinib	Y
X9b4771d72604de636d8fc01006bec3cb	12.45174538	0	82	M	Avelumab+Axitinib	N
Xf70526f340a990356b2b17324bc4ce50	17.97125257	1	51	M	Avelumab+Axitinib	NA
X17df4c8ddad623d9b80e04d8be9bf598	5.519507187	1	83	F	Avelumab+Axitinib	NA
Xdddafb0cf3edca87e72d34cd7d65d4c5	13.66735113	1	62	M	Sunitinib	Y
X1e3c3a35d1e2dfb5cc4e564bf73d2f2b	6.899383984	0	67	F	Avelumab+Axitinib	N
X85e649550a835fe5b9aa7242dc1334dd	0.032854209	1	59	F	Avelumab+Axitinib	Y
X40b3fce60ffc131fb7c7d0e4dc57d6ea	12.41889117	1	61	M	Avelumab+Axitinib	N
X073e4ec7218e717789609c79cabf8ece	12.5174538	1	68	F	Sunitinib	N
Xe201489e8158cbf66365d94c9046c7fe	12.45174538	1	69	M	Sunitinib	Y
Xbfc74502e5e2f9e11ee5c2bc3b84851a	3.942505133	0	79	M	Avelumab+Axitinib	N
X6d110edcfa19d0fafc2684ae8b8afa6b	9.659137577	1	56	M	Avelumab+Axitinib	Y
X3abf2b9a9346c01d52c76ce5dede3980	1.314168378	1	86	M	Sunitinib	Y
X610cafc680ee97aea24070005548f05a	0.032854209	1	57	M	Sunitinib	Y
Xe3b3dd3afa5b494b9dcee911f8b50548	2.726899384	0	39	M	Avelumab+Axitinib	N
Xc2a3a41db9f5fdabf96bcb01080bdeb7	5.453798768	1	73	M	Sunitinib	N
Xecba685c7ee49ce91dcb6f204ac0c406	20.79671458	1	65	M	Avelumab+Axitinib	Y
X14d943ed3c61f230f20a437693a195b8	1.478439425	0	63	M	Sunitinib	Y
X96d900a4cc196f3836671c1958e5eb33	12.5174538	1	49	F	Avelumab+Axitinib	N
X1e634d89b40d572b87cb8c782964ef56	2.825462012	0	60	M	Sunitinib	N
X507a6b65d5e4c2f63a58e14fdd6325fd	1.412731006	0	65	M	Sunitinib	Y
Xf24739e9e0b1c449447faa4cff33b97e	5.618069815	1	59	F	Avelumab+Axitinib	Y
X0de012a810cbd5283893a650dc5099a4	5.618069815	1	68	M	Avelumab+Axitinib	Y
X4410dbaa9d52c76409905072b34b1c5d	2.792607803	0	79	M	Avelumab+Axitinib	NA
Xffb8553875f8d19e4cb0c3b883220b26	7.030800821	0	65	F	Avelumab+Axitinib	Y
X2ba17c90a3c1bff4ef8827b2663120e3	1.445585216	1	81	F	Avelumab+Axitinib	N
X0131ee30a1572f16c5674577f5cf6a43	6.932238193	1	73	M	Sunitinib	Y
Xc301b4e07632485f41f4cd6816704af9	18.00410678	1	51	M	Sunitinib	N
X68003fd125e65bd2f75cb6641d6773cd	1.445585216	0	61	M	Sunitinib	N
X30165d5b06d679e87a97260760a2321d	6.965092402	0	49	M	Avelumab+Axitinib	Y
X83633277890734c074619296bcce8443	6.965092402	1	70	M	Sunitinib	Y
X46a8c75eb2f5ea2df29957ad27749d1e	20.73100616	1	73	M	Avelumab+Axitinib	Y
Xa5b3c8ab74cec6509ba4b63b74dd193b	8.377823409	1	66	M	Sunitinib	Y
X0591d2ff8464c7b3bd6dd570182325a3	1.609856263	0	45	M	Sunitinib	Y
X58586cc65d96406ecc23e19516620a47	6.965092402	1	67	M	Sunitinib	Y
Xb4e664746cbea6b38ec618cef93983e8	18.00410678	1	55	M	Avelumab+Axitinib	N
Xb9003b38b6034a93f04bce46bb86d49f	8.377823409	0	50	M	Sunitinib	N
X3de3bcd0c0874689a5e14cb96a8d8b54	18.00410678	1	63	M	Avelumab+Axitinib	N
X4f08ff8ca9c717e02f40591efc99ddbb	13.8973306	0	69	M	Sunitinib	Y
Xddf0616451cd9f7cfef532a697965c69	2.562628337	0	67	F	Sunitinib	N
X37695d12e5f7ad98d22665252947a491	8.31211499	0	65	M	Sunitinib	N
X8fc3dc71e50dfac95e2b9962a1bff5ca	6.899383984	0	36	M	Sunitinib	N
X1ee17dd8582bd966a10bb046765f5da0	15.24435318	1	34	M	Avelumab+Axitinib	N
X8c1e220212c25023f7698b4987fef769	4.106776181	0	46	F	Sunitinib	Y
Xa8196313df90e274fa5c478ddc0e3f48	1.478439425	1	60	M	Sunitinib	N
Xf2e8bbf385c2c6205d0a62ac763c6c1e	0.032854209	1	67	M	Sunitinib	Y
X531a18c617b52572555af6dbaf79d155	11.26899384	1	73	M	Sunitinib	Y
X4aa3c05a1721abdb85a8cef490bfcc80	15.08008214	1	65	M	Avelumab+Axitinib	Y
Xdae098d1f553b8ad7b29b7260d8cd815	11.30184805	0	66	M	Sunitinib	N
X693eb00264592bf8cdde068dfd8b13e4	6.800821355	0	50	M	Sunitinib	Y
Xceed74a24dea8bbb00de34feee199cdc	10.25051335	1	70	M	Avelumab+Axitinib	Y
X519b745128d6dd46890a1dd16adf8bf2	8.410677618	1	35	M	Sunitinib	Y
Xc6f9674d8473b628a802595c2f5880ea	5.519507187	1	70	M	Avelumab+Axitinib	Y
X188bc1d97d61f0caececb8fe2eeed462	20.73100616	0	65	M	Sunitinib	N
Xa9894c70216514219b5f0f25e1722e32	8.344969199	1	64	M	Avelumab+Axitinib	Y
X28bfb0c27e7fdb1be3ae4ad978dc782e	6.965092402	1	64	M	Avelumab+Axitinib	Y
Xd638828ea3a561ed62fdc4786771b528	1.412731006	0	69	M	Avelumab+Axitinib	Y
Xa09b7a199303d519d339c9f769d9b9dc	9.724845996	0	67	M	Sunitinib	Y
X4655521427a19071f4602892abcc0267	9.889117043	0	68	F	Avelumab+Axitinib	NA
Xef16d6de92fa55e092482ff6e0e377da	8.377823409	1	63	M	Sunitinib	N
Xcd42ec62c52ed2d7d4501b1f0b35c658	1.412731006	1	77	M	Sunitinib	N
Xf00fc26b8ce31e7a40ec44b8f0939be3	5.749486653	1	54	M	Sunitinib	N
Xcdaf1a47e636b818a05fc059e5e7362e	0.032854209	1	39	M	Avelumab+Axitinib	N
X2d5b794b4a59d862d8d75f411db99898	2.726899384	1	62	M	Avelumab+Axitinib	N
X423ad12945144a8996111444ad911c26	1.412731006	0	67	M	Sunitinib	N
X9b1952ff2f60a44272d3fdd1b0cfce64	11.07186858	0	66	F	Avelumab+Axitinib	N
X2069a43cf26725e339dae5a64490a17f	1.379876797	0	27	F	Sunitinib	N
Xfcf883ad693b49b5821616119ad680fd	6.932238193	0	69	M	Sunitinib	Y
Xf0288a91968b576b8a7ec5d40a0cc370	2.825462012	0	59	M	Sunitinib	Y
X7b97ab8789ce36d8bb74bad9392c7bcc	11.17043121	0	61	M	Sunitinib	Y
X9266c402a946811edc6ff09679d86446	0.032854209	1	78	M	Sunitinib	Y
X8c4f665ec25889af0c768593876795f5	5.716632444	0	57	M	Avelumab+Axitinib	NA
Xfa8ee8a5cf3379d856208707cbdd3f92	2.924024641	0	52	M	Sunitinib	Y
Xf292e08727af4605aed7f4d3abe98737	8.542094456	0	60	M	Avelumab+Axitinib	NA
Xb174a22946d23624c5dccc28f9360223	9.691991786	0	56	M	Avelumab+Axitinib	Y
X8827ffec37986c3ee2591d53209b642d	2.792607803	0	57	F	Sunitinib	NA
X8fd2b38971ab6febeed1416b6705c8ce	11.10472279	1	72	F	Sunitinib	N
Xb9a88a74014394a5c6041008cdcb7057	7.392197125	1	74	M	Sunitinib	N
Xc0cc0396486ebcac697a04be687c0944	0.032854209	1	60	M	Sunitinib	NA
Xe761ceb4a7b55e5c5c994435182ed394	7.852156057	1	66	M	Sunitinib	Y
X7d5162ec6765b6e9d010b9ce94f421ca	8.180698152	1	57	M	Sunitinib	NA
Xdf5868027d40950ed7db528969acf608	7.030800821	0	83	M	Avelumab+Axitinib	Y
Xb189b81f9e68ffab81e1791094e8bf89	6.833675565	0	55	M	Sunitinib	Y
Xff3c7b640e8f8b629ae44bf9914bdabb	5.519507187	1	61	M	Avelumab+Axitinib	N
Xf1c001fc4a606ec3775852226bba646a	14.09445585	1	56	M	Avelumab+Axitinib	Y
Xd6f8c28242e48d91ef4bc598cb9e617b	2.299794661	0	55	M	Avelumab+Axitinib	Y
X3cb57b447fb341543cff3e0fa3bd241c	11.03901437	1	64	M	Avelumab+Axitinib	Y
X7331ed3730c6913b1d0e609095a9ad69	3.252566735	1	43	M	Avelumab+Axitinib	N
Xfcedaa76e45d0f17694bda70a3e91fb3	17.80698152	1	58	F	Sunitinib	N
X11fce3363f7481501759a4cfa960c7b2	1.478439425	0	78	F	Sunitinib	Y
X5662bd7ed1c9e11ee8cd047c10d281e3	3.121149897	0	68	M	Sunitinib	N
Xbe78ca3c4574d60a753d70731a52bc0e	6.702258727	1	71	F	Sunitinib	Y
Xc8e4a2ab35f44b70241633b78606dbb7	1.379876797	0	57	M	Sunitinib	Y
Xa20db00649a026cd61325d802c1b2ed0	9.724845996	0	67	M	Sunitinib	Y
Xf70b0c5dacaddf40ca7e402c8f7b5f6f	2.792607803	1	58	M	Sunitinib	N
Xb59a017b94ebd67542acfeefdfb9b695	5.749486653	0	67	M	Sunitinib	NA
X4a6d350bfb1c3a69f8ce570498cc6f7d	13.79876797	0	46	M	Sunitinib	N
X7497144f2ef21e19c254fabd5639413b	18.23408624	1	65	M	Avelumab+Axitinib	Y
X92da4f0f17bf64a7f3c4b7c9970869ea	9.691991786	0	62	M	Avelumab+Axitinib	Y
X510c6ec5d94c0fd563a1f2b7e5e938cd	3.811088296	0	68	F	Avelumab+Axitinib	Y
X8f59876cddb394193004de168c132baf	9.724845996	0	76	M	Avelumab+Axitinib	Y
X0c38f986cbea173cbafc957bfd0b28d8	6.997946612	1	40	M	Avelumab+Axitinib	Y
X4f12e17b391b9f744fbfef42c528826a	2.661190965	1	56	M	Avelumab+Axitinib	N
X48ebdf79e99261ca64ec89fa7cac2e00	11.92607803	1	65	F	Avelumab+Axitinib	Y
Xe0f58bb185e45c7a3fa81f212570636f	9.757700205	0	61	M	Sunitinib	N
X8710d098169fa294d03d1b5cacdc2f7a	2.628336756	0	69	M	Sunitinib	Y
X05d22214a12074d176162b3d3d206363	15.3100616	0	53	M	Avelumab+Axitinib	N
X8783adc097e910b52c11f50e2a4aff2a	9.626283368	0	59	M	Avelumab+Axitinib	Y
X6f5c1c6ee29562e92b675186a9a24770	5.552361396	0	70	F	Avelumab+Axitinib	Y
Xf38ca769a89025901a144cbbe657da6c	11.10472279	0	55	M	Avelumab+Axitinib	N
X2f399a936f871f31bca98d92bb413cbe	13.79876797	1	58	M	Sunitinib	N
X01cd596f6ffe5ddd5791b98b90f0a006	2.431211499	0	55	M	Sunitinib	NA
X5063c34f9a841ad4a0c53dde5f42473e	14.2587269	1	62	M	Avelumab+Axitinib	N
X5b5e39b2215dcb24bf216ccbf6166e39	8.772073922	0	77	M	Avelumab+Axitinib	Y
Xdfdfed054a070b6d003e028c7fe428cf	12.71457906	1	56	M	Avelumab+Axitinib	Y
X7565bd61ff48ecf1dc2ff93b3e803295	13.73305955	1	67	F	Sunitinib	NA
X9f70446324bb6710757ebed4fa864a3f	1.379876797	0	38	M	Sunitinib	Y
Xafe2a1d9725188b3e4e08acb09bc31dd	0.032854209	1	65	F	Sunitinib	N
X8b1f89af33679450b821013822ceb1ae	5.519507187	1	49	M	Avelumab+Axitinib	NA
Xd041787a5e525c2edaaa90a843640bb9	5.519507187	1	71	F	Sunitinib	Y
X30ee743b7fde59d25ee30303eb699e31	4.829568789	1	61	M	Avelumab+Axitinib	Y
X40f2f3210695eef9940acf149b2d96ae	11.10472279	1	51	M	Sunitinib	N
X342758d6ea21d1386905ac1ebd7b325e	8.246406571	0	65	M	Avelumab+Axitinib	N
Xcbe29b67a8243fe575c88ed8e2c2afde	0.032854209	1	64	M	Sunitinib	N
Xa3e41989c4df89d004d738e3104e0f1d	0.032854209	1	69	M	Sunitinib	N
X16976202f690ab9fcaedacc52f5cb27f	6.702258727	0	61	F	Avelumab+Axitinib	Y
Xd0f2cfdd56f97f8a13f58e6b2ba583d3	9.889117043	1	65	M	Sunitinib	N
X593df5fbb758a91e262411484346d0a2	4.13963039	0	70	M	Avelumab+Axitinib	N
Xcfacb7eb725aa51c8def27f8bd09b2c9	9.724845996	1	53	F	Avelumab+Axitinib	Y
X5f49414082930ad3d6faa26afe948131	8.410677618	1	74	F	Avelumab+Axitinib	Y
X0f828e9106d704b282e2f18107fb6b7a	7.030800821	1	50	F	Sunitinib	N
X60e548e4beac14fd27d9a41556a076aa	8.607802875	1	55	M	Avelumab+Axitinib	Y
X685cba32c121cfd38e705f0a1b19494f	0.032854209	1	66	M	Avelumab+Axitinib	NA
Xb9859ece5e81e4f21ef40665928a5526	8.27926078	1	70	F	Sunitinib	Y
Xea2a3b33b1273d60fe78d41efd2c930d	4.13963039	0	64	M	Sunitinib	Y
X47810e4a1d20c07f975b3546767ef2a0	5.782340862	1	62	M	Avelumab+Axitinib	Y
X5709f9e5805825fc3821f22c7b148137	20.79671458	1	59	F	Sunitinib	N
Xbb1c5a25e8abc5f7b1bfae0a7dfe4a1a	1.445585216	1	63	M	Sunitinib	Y
Xdfcf5305535621a96b578113a61d1144	11.10472279	1	59	M	Avelumab+Axitinib	Y
Xb219770dd39b0a33a2a5aab580e38f48	1.347022587	0	66	M	Sunitinib	Y
X537dfe703f9be6f7b41b45d720e48d46	1.347022587	0	57	M	Sunitinib	Y
X4fa2a1b3738de2989fb9621b6895af41	0.032854209	1	51	M	Avelumab+Axitinib	Y
X3a136cd62607201b4a5025d1b5368c40	6.899383984	1	67	M	Avelumab+Axitinib	Y
Xe56964515d4aa080ba8350f66b89b1ca	6.932238193	0	46	M	Sunitinib	Y
X5a41fda56b2bee63aff3c5f90ef6b3e9	10.94045175	1	60	M	Avelumab+Axitinib	N
Xddc4ff1849070c7b6d678bb059022f12	10.87474333	1	44	M	Avelumab+Axitinib	Y
X941fc436adec159e7f469ce22721c0f9	2.759753593	0	54	M	Sunitinib	Y
X3cdb45cfe9ffaac83f36c75e4af759e6	3.745379877	0	50	F	Avelumab+Axitinib	Y
X34af9fb58cf5136b9863f09f90309afd	6.899383984	1	55	M	Avelumab+Axitinib	Y
X1692599f3867c8e12b6bf09046771943	7.030800821	0	58	M	Avelumab+Axitinib	Y
X066163adb7ac97187777f99246ade71a	16.59137577	1	59	F	Avelumab+Axitinib	Y
X4ad56c7ed6c731462c83bd188e409ca3	12.45174538	0	67	M	Avelumab+Axitinib	N
Xc0508e72d4208c53e2254e274a8343f8	0.459958932	0	58	M	Avelumab+Axitinib	NA
X45894bc3efe4b9fb756b9b60d860524d	6.965092402	0	68	F	Avelumab+Axitinib	Y
Xb3e8f4122cb2e99b707d84ab8a095010	1.609856263	1	67	M	Avelumab+Axitinib	Y
Xe12b6ec846380a39d2773f311283b963	12.5174538	1	64	M	Sunitinib	N
X81ae53f960bcd1f54d83486363c634b3	12.5174538	1	58	M	Sunitinib	N
Xb3254d9ca8c2357de69574349bc731b7	12.5174538	1	60	M	Avelumab+Axitinib	NA
X60a9f6d7ccb1fb6365502c254302acbc	12.45174538	1	81	M	Sunitinib	Y
X3db1a6d0d06440f66429056e3727fab5	9.691991786	1	75	M	Avelumab+Axitinib	Y
X10ec23fa07eea3d69a7769af58732d4f	0.032854209	1	64	F	Avelumab+Axitinib	Y
X05e7559b15212b2748bc0a5133f85a3b	8.213552361	0	56	F	Sunitinib	Y
X927e37ac4383ed6389d1d0db6ab904b7	9.889117043	1	70	F	Sunitinib	Y
Xac23ea23d161c0a4894912f42b8e0b9b	9.691991786	1	53	M	Sunitinib	Y
X503d4b91a21946b28d89bbc0a6ff1c0c	9.691991786	1	43	M	Avelumab+Axitinib	Y
X7d84f93927db305825400d52fe2467ac	2.98973306	0	64	M	Avelumab+Axitinib	Y
X374e432074fbccc257907b977e27c34d	1.511293634	0	55	M	Sunitinib	Y
X1d48bf3546928a7daae0c66e79c9f276	8.31211499	1	67	M	Avelumab+Axitinib	Y
X83f4c7f066c22ff82ffdda3a819f401c	8.443531828	1	69	F	Sunitinib	N
X1cb1841daad70ef7c6839b5f9d545558	8.31211499	1	63	M	Avelumab+Axitinib	Y
X3591e786d7e1feb1237e5b3025071c62	8.377823409	1	70	F	Avelumab+Axitinib	Y
Xe8fd7e061dc695303531468579ce9cbb	7.12936345	1	34	M	Avelumab+Axitinib	Y
Xd184c87875774aa04ad76b5cd0528c63	8.410677618	1	62	M	Sunitinib	Y
X6f15579e208a9524c4a36704207b706e	6.965092402	1	74	M	Sunitinib	Y
X6beb5548a8060d418335891d98ea8781	6.997946612	1	51	F	Avelumab+Axitinib	Y
X3dbc4bc73dfba4629ad5fef29a99f7e7	6.997946612	1	60	F	Avelumab+Axitinib	Y
X91a68b73b9ef311d3a6f598a10b8d369	5.618069815	0	67	M	Avelumab+Axitinib	Y
Xbc4c8813c6187c40f17ccf1d24486bc3	8.31211499	0	50	M	Avelumab+Axitinib	Y
Xc4531564504768a8e450ec744e45e280	2.135523614	0	47	M	Sunitinib	Y
Xcad1fd440c471f7904a591829cb6d14b	13.83162218	1	52	M	Avelumab+Axitinib	Y
X80f9a88517555f71e441163428db8371	2.759753593	0	45	M	Avelumab+Axitinib	Y
Xfd354971867b62382812e27e3df227ba	8.213552361	1	45	M	Sunitinib	Y
X1e39e20ab185c73fe60fa6b396eccee6	20.92813142	1	52	M	Avelumab+Axitinib	NA
Xd75c42896884149be997c920b5592e16	11.07186858	0	59	M	Sunitinib	Y
Xff9a5e547f4e630f903268749c2c4e62	18.20123203	1	69	M	Sunitinib	Y
X5b4f66ac7b0e9731f0e2d09b9ce2bc83	15.21149897	1	38	F	Sunitinib	Y
Xe9433456121a8710f455344dc9c484c7	5.585215606	0	62	M	Avelumab+Axitinib	Y
X76d17bde5ef4f59248f2dfadb6ba27ee	12.58316222	0	66	F	Avelumab+Axitinib	N
X2bf0d2c891632c9eecb7cb7ca0bbdc35	11.07186858	1	78	M	Sunitinib	Y
X56517cd1ff5c36c94c351f69437a110d	11.20328542	1	56	M	Avelumab+Axitinib	Y
Xd8e8c017486e406242b07478a146f2fd	9.691991786	1	80	M	Avelumab+Axitinib	N
X455848b4836fafe39ae8cc9642cb5596	9.823408624	1	43	F	Avelumab+Axitinib	Y
X817e526c2151c4ab002749fe28509cf8	6.932238193	0	49	M	Avelumab+Axitinib	N
X1fc17d39813bb21078851cf009f5bdc5	6.932238193	1	69	M	Avelumab+Axitinib	Y
X7533d8277a20dfb0c88915db24868ee9	0.755646817	0	65	F	Avelumab+Axitinib	Y
X2f8b8e5b906efb5430f51da0791e15d3	6.932238193	1	85	F	Sunitinib	NA
Xff34dbd0f069670a20827e31b8026144	5.618069815	1	68	M	Avelumab+Axitinib	Y
X3b785dfe51f758e18bca243f56b5117e	11.23613963	1	42	M	Avelumab+Axitinib	Y
Xd75ed5f9c7d87e82a415eae46b306612	12.38603696	1	72	M	Avelumab+Axitinib	Y
X03d41da0d229c0dba90b40b08f5524b7	8.344969199	1	50	M	Avelumab+Axitinib	Y
Xb75f823803af55f1de150e4f4de3312c	2.628336756	1	70	M	Avelumab+Axitinib	N
Xb28579e19904ad37116121b7a3d6d5e6	15.3100616	1	63	M	Sunitinib	N
X1ed22c1e4b51a9aa893333101336d863	11.20328542	0	56	M	Sunitinib	N
X211c2e0bb90037d7c0285da1025e5b59	12.84599589	1	67	M	Avelumab+Axitinib	Y
X0ee8d1a975ee6587e16f1baba3214614	0.032854209	1	63	M	Sunitinib	NA
Xc52dd1f0ac3ca0c519e06ffef31d20a2	11.30184805	1	53	M	Sunitinib	Y
Xf356612bfb14f579d0109dd28a074fac	4.303901437	0	51	M	Avelumab+Axitinib	Y
X494323795b1fb3c6376fd2e364ffcb24	8.377823409	0	59	M	Sunitinib	Y
X070737943aa2690378c5d73bdea647d7	7.030800821	0	58	M	Avelumab+Axitinib	N
Xfbff2fd623efaaa23c9da75cb2084925	7.030800821	1	48	M	Avelumab+Axitinib	Y
X2054c008048647e0d579d793fe45ee7a	1.478439425	0	56	F	Avelumab+Axitinib	N
Xedce4709eebc28be5631985036add223	1.642710472	0	54	M	Sunitinib	Y
Xa56451dc798e027e9f430ca06fdaffea	0.032854209	1	63	M	Avelumab+Axitinib	NA
X1ca582a355616189ed5be11c257b9a31	5.388090349	1	66	M	Sunitinib	Y
Xef4f150cebd077a4f5e01fe216d60dee	5.585215606	1	76	M	Sunitinib	NA
X20ea35d787f94b54b3432014f9897c2b	17.97125257	1	43	M	Sunitinib	Y
X90d98471d59b5c0b179e8e38e9c566fc	9.724845996	0	56	M	Avelumab+Axitinib	Y
X47001a91d71acb95bb7a3d249baa19ee	8.377823409	0	38	M	Avelumab+Axitinib	Y
Xa7d2bd80340b4019986ea8d8c3638c75	12.58316222	1	59	M	Sunitinib	N
Xbc7a029dc7ce4b19a5a2b78a7b2fc6ae	2.792607803	0	43	M	Avelumab+Axitinib	Y
X13b911b56a330efd2660b67b1cf98466	2.924024641	0	65	M	Avelumab+Axitinib	Y
X9388bd484d0e404c6732573b4228d2a2	4.1724846	0	53	F	Avelumab+Axitinib	Y
Xc3d410d70dd7359baa40126494fb6765	9.790554415	1	49	M	Sunitinib	N
X50772aa64efb859960b20f8801cd6f58	4.271047228	0	65	M	Sunitinib	N
X91bcd3067a1a7954692d836515e04869	2.496919918	0	57	M	Sunitinib	Y
Xf2d7ca0422d5cfff11852a4933c8915d	1.445585216	1	67	M	Sunitinib	NA
Xc7439a06ffa32b313b0ec1b987b992a2	6.50513347	1	43	M	Avelumab+Axitinib	N
Xec760e642aeb6c4b26c912213d84f20b	6.866529774	1	65	F	Avelumab+Axitinib	N
X21a6043653d187f8bbead475d2f49791	5.683778234	1	79	M	Sunitinib	N
Xa021f5de25a2ffa059870f059a65d075	4.106776181	1	73	F	Avelumab+Axitinib	Y
X05275c12e66dfefd10a3642818e862f7	8.344969199	1	62	F	Avelumab+Axitinib	Y